PVALB and schizophrenia: Similar to the findings in schizophrenia patients, these animals also show a reduction in mPFC levels of the GABA marker parvalbumin and impaired GABAergic inhibition of mPFC pyramidal neurons which is thought to underlie the selective EDS impairment seen in these subjects [46–47].